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Introduction and Aims: Recovery of renal function after liver transplantation is
strongly influenced by pretransplant degree and duration of renal insufficiency, despite
imprecise methods for measuring renal dysfunction. Indications for combined
liver-kidney transplantation (CLKT) have been defined, but these are still under debate
and hepatorenal syndrome (HRS) is a particularly challenging condition given the
hardly predictable spontaneous improvement with liver transplant alone (LTA).
Methods:We analysed data of 6035 patients (Jan 2001-Dec 2012) from NHSBT UK
Transplant Registry. Renal function at 1 years after transplantation was compared
between CLKT and LTAwith stratification on the basis of glomerular filtration rate
(eGFR) at transplant (KDIGO Guidelines) and treatment with renal replacement
therapy (RRT). Renal function post-transplantation was classified as eGFR >60,
between 59-30 and <30 ml/min/1.73m2, the latter identified as non recovery of renal
function. Univariate and multivariable analysis were performed.
Results: 5912 patients (98.0%) underwent liver transplant alone (LTA) and 123 (2.0%)
patients received a CLKT. 305 (5.2%) of the LTA group were on RRT at time of
transplantation, compared to 72 (58.5%) of the CKLT group. No patient with a MELD
score <20 received RRT before transplant. No patients with eGFR ≥60 mL/min/1.73m2
received CLKT. 27% of patients receiving CLKT were diagnosed with pre-transplant
glomerular/tubular kidney disease, 39% with polycystic disease and 34% were not
specified. LTA patients on RRT were more frequently presenting ascites (p<0.001),
variceal bleeding (p=0.002), higher MELD score (p<0.001), higher INR (p<0.001) and
bilirubin at transplant (p<0.001), suggesting the occurrence of HRS (data not
available). Patients on RRT experience a significant difference of renal function
recovery at 1 year post-transplant when receiving LTA versus CLKT, with the latter
group experiencing a higher percentage of non-recovery (p=0.001; table 1). This
difference was not detected for other eGFR stratifications.The univariate analysis
identified recipient age >50 years, female gender, RRT in patients with MELD >20,
polycystic disease and diabetes as predictive factors for non-recovery of renal function
in patients undergoing LTA. In a multivariable model including all clinically relevant
variables simultaneously, the independent predictors of renal function non-recovery
were female gender (HR 2.76; 95% CI 1.52-4.99, p=0.001), RRT in patients with MELD
>20 (HR 3.62; 95% CI 1.44-9.08, p=0.006) and diabetes (HR 2.55; 95% CI 1.38-4.73,
p=0.003).
Conclusions: Recovery of renal function post-LTA is acceptable for patients with
different stratifications of eGFR pre-transplant. RRT, female gender and diabetes may
suggest to perform CLKT.
SP665 Table 1:
eGFR <30mL/min eGFR≥30 mL/min
LTA (244 pts) 14 (5.7%) 230 (94.3%)
CLKT (63 pts) 6 (9.5%) 57 (90.5%)
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